SRF Limited has announced a significant leadership appointment with the selection of Mr. Samir Kashyap as President & Chief Financial Officer, designated as Key Managerial Personnel. The appointment, effective January 27, 2026, was approved by the Board of Directors on January 20, 2026, following recommendations from both the Nomination and Remuneration Committee and Audit Committee.

Appointment Details

The company disclosed the appointment under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The following table outlines the key details of Mr. Kashyap's appointment:

Professional Background and Experience

Mr. Kashyap brings extensive leadership experience to SRF Limited, with over 30 years of overall professional experience. His career includes two decades specifically in CFO capacity at renowned organizations including Meta, SAP, and Genpact LLC. Throughout his career, he has demonstrated a proven history of managing high-performing finance teams and driving growth in technology businesses across both emerging and developed markets.

Areas of Expertise

The new CFO's diverse experience encompasses multiple critical areas that will benefit SRF Limited's operations:

• Finance and digital transformation initiatives
• Business partnering to unlock growth opportunities
• Strategic planning and profitability management
• Corporate finance and post-M&A integration
• Investor and stakeholder management
• Corporate governance frameworks

Mr. Kashyap has successfully built and inspired diverse teams overseeing various functions including business controllership, accounting and reporting, financial planning and analysis, compliance, and procurement. His consulting experience spans corporate and international tax planning, tax compliance, business and transaction advisory, M&A activities, due diligence, investment structuring, and business setup.

Educational Qualifications

Mr. Kashyap holds strong academic credentials with a B.Com (H) degree from Shri Ram College of Commerce and is a qualified Chartered Accountant (C.A.). This combination of academic foundation and professional certification aligns with the financial leadership requirements of SRF Limited.

Regulatory Compliance

The appointment fulfills SRF Limited's regulatory obligations under SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The company confirmed that Mr. Kashyap has no relationships with existing directors, ensuring independence in his role as Key Managerial Personnel.

SRF Limited has announced the approval of a new pharmaceutical intermediates manufacturing plant in Dahej, Gujarat, marking a significant expansion in the company's manufacturing capabilities. The project involves a total investment of ₹180.00 crores and represents SRF's strategic entry into the pharmaceutical intermediates sector.

Investment Details

The company's board has approved the establishment of this new facility with the following key parameters:

Strategic Expansion

The Dahej pharmaceutical intermediates plant represents SRF's diversification strategy beyond its traditional chemical and specialty products business. Pharmaceutical intermediates are essential components in the pharmaceutical supply chain, serving as building blocks for active pharmaceutical ingredients and finished drug products. This expansion positions SRF to capitalize on the growing demand in the pharmaceutical sector.

Facility Location

Dahej, located in Gujarat, is a well-established industrial hub with excellent infrastructure and connectivity. The location offers strategic advantages including proximity to ports for raw material imports and finished product exports, along with access to skilled workforce and industrial support services. The facility will add to SRF's existing manufacturing footprint across multiple locations.

Business Impact

This investment demonstrates SRF's commitment to expanding its product portfolio and entering high-growth sectors. The pharmaceutical intermediates business typically offers stable demand patterns and attractive margins, providing the company with additional revenue streams and reduced dependence on traditional chemical products. The new facility will enhance SRF's manufacturing capabilities and strengthen its position in the specialty chemicals ecosystem.